# Risk-based Gap Analysis

Act as a regulatory scientist experienced in GLP preclinical work. Compare the existing study plan for a [medical device name] to FDA 21 CFR Part 58, ISO 10993, and FDA's "General Considerations for Animal Studies Intended to Evaluate Medical Devices." Highlight any deficiencies, reference the specific regulation or guidance, and propose corrective actions. Format as a two-column table with "Identified Gap" and "Proposed Remediation."
